Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial

David Sebag‐Montefiore(University of Leeds), Mahesh Parmar(University College London), R. Steele(University of Dundee), E.M. Bessell(University Hospitals Birmingham NHS Foundation Trust), Lindsay C Thompson(MRC Clinical Trials Unit at UCL), Philip Quirke(University of Leeds), Catherine de Metz(Ontario Institute for Cancer Research), Richard Stephens(Keele University), Gareth Griffiths(NIHR Evaluation Trials and Studies Coordinating Centre), Subhash Khanna(Leicester Royal Infirmary), Robert Grieve, John R.T. Monson(Northwell Health), Jean Couture(Ontario Institute for Cancer Research), Arthur Sun Myint(University of Liverpool)
The Lancet
March 1, 2009
10.1016/s0140-6736(09)60484-0
Cited by 1,511

Related Papers

2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
|European Heart Journal|2022|2.7k
Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial
|The Lancet|2015|2k
Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy
|New England Journal of Medicine|2017|1.8k
Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2020|1.3k
Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial
|The Lancet|2009|1.1k